The	O
patient	O
was	O
transferred	O
here	O
after	O
stopping	O
of	O
the	B-treatment
continuous	I-treatment
infusion	I-treatment
heparin	I-treatment
and	O
receiving	O
a	B-treatment
dose	I-treatment
of	I-treatment
Lovenox	I-treatment
60	O
mg	O
subcutaneously	O
for	O
further	O
diagnostic	O
evaluation	O
and	O
management	O
of	O
the	O
acute	B-problem
lymphoblastic	I-problem
leukemia	I-problem
(	I-problem
ALL	I-problem
)	O
.	O
